Related Experiment Video
Updated: Mar 6, 2026

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
Tet2 modulates ER stress responses related to β-cell death and autoimmunity in diabetes
Jinxiu Rui1, Madhav Kothari2, Romy Kursawe2
1Department of Immunobiology, New Haven, CT, USA.
Abstract:
We found that beta cells from Tet2-deficient mice were protected from killing in a model of autoimmune Type 1 diabetes, but the mechanism of protection and specific cell types affected by Tet2 loss were unknown. Herein we show that in Tet2-deficient NOD mice transplanted with wild-type bone marrow, there are fewer islet infiltrating lymphocytes beginning 8-10 weeks after transplant, which was seen primarily among CD4+ T-cells. Transcription factor binding motifs for interferon responses factors and inflammatory signaling molecules were enriched in Tet2-responsive cis-regulatory elements across all KO islet endocrine cells, but we observed beta cell-specific enrichment of TFs modulating homeostatic or ER stress response pathways. To determine whether there were similar effects in human islets, we induced ER stress with brefeldin A or thapsigargin and inhibited TET2 with Bobcat 339. Pharmacologic TET inhibition reduced expression of ER stress response genes, inflammatory responses, and stress-induced beta cell death. We conclude that Tet2 (TET2) can regulate ER stress responses involved in beta cell killing in autoimmune/inflammatory settings.
Insights
Tetraplegin-2 (TET2) deficiency protects beta cells from autoimmune Type 1 diabetes by reducing inflammatory T-cells and modulating ER stress responses. This finding offers new insights into beta cell protection mechanisms in autoimmune settings.
Area of Science:
- Immunology
- Endocrinology
- Molecular Biology
Background:
- Beta cells are crucial for glucose regulation and are targeted in Type 1 diabetes.
- Tetraplegin-2 (TET2) has been implicated in immune regulation, but its role in beta cell protection during autoimmune diabetes is unclear.
Purpose of the Study:
- To elucidate the mechanism by which TET2 deficiency protects beta cells in a Type 1 diabetes model.
- To investigate the impact of TET2 loss on immune cell infiltration and beta cell stress responses.
Main Methods:
- Utilized Tet2-deficient NOD mice transplanted with wild-type bone marrow to study immune cell infiltration.
- Analyzed transcription factor binding motifs in Tet2-responsive cis-regulatory elements.
- Investigated the effects of TET2 inhibition on human islets under endoplasmic reticulum (ER) stress conditions induced by brefeldin A or thapsigargin.
Main Results:
- Tet2 deficiency led to reduced islet-infiltrating lymphocytes, particularly CD4+ T-cells, in NOD mice.
- Beta cell-specific enrichment of transcription factors involved in homeostatic and ER stress pathways was observed in Tet2-deficient islets.
- Pharmacologic inhibition of TET2 in human islets reduced ER stress response genes, inflammatory responses, and stress-induced beta cell death.
Conclusions:
- TET2 plays a role in regulating ER stress responses that contribute to beta cell death in autoimmune and inflammatory conditions.
- TET2 inhibition may represent a therapeutic strategy for protecting beta cells in Type 1 diabetes.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Regulation of the Unfolded Protein Response

